Skip to content
Clinical Trials – home

Lung disorder Life with Disease

0 / 3 trials open to patients14 countries

In short

Lung disorders encompass a wide range of health conditions that affect the airways, lung tissue, blood vessels, or the lining of the chest cavity. These conditions can dramatically alter how people breathe, move, and live their daily lives, requiring careful management and support from medical teams and loved ones.

Key points

  • Most lung diseases are chronic lifelong conditions, but proper treatment can slow progression and maintain quality of life for many years.
  • Lung damage cannot be reversed, but stopping smoking—even with advanced disease—dramatically slows further deterioration and remains the most important intervention.
  • Shortness of breath isn't just about breathing—when lungs don't work properly, it can lead to dangerous complications affecting the heart, blood oxygen levels, and overall body function.
  • Simple daily activities like dressing or climbing stairs can become exhausting challenges, requiring creative adaptations and energy conservation strategies.
  • Staying vaccinated against flu and pneumonia is critical since respiratory infections can be particularly dangerous for people with underlying lung disease.
  • Pulmonary rehabilitation programs combining exercise, education, and breathing techniques significantly improve quality of life and daily functioning capabilities.
  • Clinical trials may offer access to promising new treatments, and family members can provide invaluable support in exploring and participating in research opportunities.
  • Living with lung disease affects emotional wellbeing as much as physical health—support groups and self-management programs reduce isolation and improve coping strategies.

Understanding What to Expect: Prognosis

When someone receives a diagnosis of lung disorder, one of the first questions that naturally arises is: what happens next? The answer depends heavily on which specific condition affects the lungs and how far it has progressed. Understanding prognosis can help patients and families prepare emotionally and practically for the road ahead.

Most lung diseases are chronic, meaning they develop over time and often last for years or even a lifetime. Some individuals are born with conditions like cystic fibrosis, while others develop problems such as chronic obstructive pulmonary disease (often shortened to COPD) later in life, frequently due to smoking or environmental exposures. A smaller group of lung conditions, particularly infections like pneumonia, can be treated and resolved relatively quickly.

The long-term outlook varies dramatically. For example, people with well-controlled asthma can lead completely normal, active lives with proper medication and avoiding triggers. However, conditions like idiopathic pulmonary fibrosis carry a much more serious prognosis. Without treatment response, patients with this progressive scarring disease may face a life expectancy of only two to three years from diagnosis.

Rate of disease progression also differs greatly between conditions and between individuals with the same condition. Idiopathic pulmonary fibrosis, for instance, is highly variable in how quickly it advances, making it difficult for doctors to predict changes over short periods. Some lung diseases may be responsive to treatment in early, more inflammatory stages, which is why starting therapy as soon as possible can be crucial.

It's important to understand that lung function, once damaged, cannot be fully restored. However, this doesn't mean improvement is impossible. With proper treatment, many people can slow disease progression, reduce symptoms, and maintain quality of life for many years. For those with severe disease who don't respond to medical therapy, lung transplantation may become an option.

How Lung Disorders Progress Without Treatment

Understanding the natural course of untreated lung disease helps explain why early diagnosis and intervention matter so much. When lung disorders go unaddressed, they typically worsen over time, though the speed and pattern of decline varies by condition type.

In airway diseases such as asthma or COPD, the tubes that carry air in and out of the lungs become increasingly narrow or blocked. People often describe this sensation as trying to breathe through a straw. Over months and years, repeated inflammation and damage can permanently alter the structure of these airways, making breathing progressively more difficult. With emphysema, a form of COPD, the delicate connections between air sacs break down, trapping air in the lungs and making it extremely hard to push air out.

Lung tissue diseases like pulmonary fibrosis involve scarring or inflammation that stiffens the lungs. Without intervention, this scarring gradually spreads, preventing the lungs from expanding fully. As the tissue becomes increasingly rigid, the body struggles to take in sufficient oxygen and expel carbon dioxide. People with these conditions often say it feels like wearing a vest that's too tight.

Lung circulation diseases affect the blood vessels running through the lungs. When these vessels become damaged by clotting, scarring, or inflammation, oxygen transfer between lungs and blood becomes impaired. This can also strain the heart, which must work harder to pump blood through damaged lung vessels.

Many lung diseases combine elements of all three categories as they advance. The progressive nature of most chronic lung conditions means symptoms that were once manageable can become increasingly severe, limiting physical activity, disrupting sleep, and affecting overall health. This is precisely why stopping smoking represents the single most important intervention for people with smoking-related lung disease. While quitting cannot reverse damage already done, it can dramatically slow further deterioration, even in advanced disease.

Complications That May Develop

Lung disorders don't just affect breathing—they can trigger a cascade of other serious health problems throughout the body. Understanding these potential complications helps patients and families recognize warning signs and seek timely medical attention.

One frightening complication is respiratory failure, where the lungs can no longer adequately supply oxygen to the blood or remove carbon dioxide from the body. This life-threatening situation may develop suddenly during an infection or gradually as chronic disease worsens. Related to this, hypoxemia (low oxygen in the blood) and hypoxia (low oxygen in body tissues) can develop, depriving vital organs of the oxygen they need to function.

The buildup of carbon dioxide in the blood, called hypercapnia, represents another dangerous complication. When lungs cannot effectively expel carbon dioxide during exhalation, this waste gas accumulates in the bloodstream, potentially causing confusion, drowsiness, and other serious symptoms.

Structural problems can also arise. A pneumothorax, or collapsed lung, occurs when air leaks into the space between the lung and chest wall. Pleural effusion, the abnormal accumulation of fluid around the lungs, can compress lung tissue and make breathing even more difficult. Both conditions may require urgent medical procedures to resolve.

Lung disease can also affect the heart, particularly the right side that pumps blood through the lungs. When damaged lungs develop high blood pressure in their vessels (pulmonary hypertension), the right side of the heart must work much harder. Over time, this can lead to cor pulmonale, a type of right-sided heart failure that develops as a consequence of lung disease.

Impact on Daily Life

Living with a lung disorder affects far more than just breathing—it touches nearly every aspect of daily existence, from physical activities to emotional wellbeing, social interactions, work capabilities, and leisure pursuits. Understanding these impacts can help patients and families develop realistic expectations and effective coping strategies.

Physical limitations often become the most immediately apparent challenge. Simple activities that once required no thought—climbing stairs, carrying groceries, getting dressed, or taking a shower—can leave someone with lung disease breathless and exhausted. Many people find they need to slow down, take frequent rest breaks, or completely modify how they accomplish daily tasks. For instance, keeping frequently used items within easy reach eliminates unnecessary trips around the house. Breaking household chores into smaller segments spread throughout the day, rather than tackling everything at once, helps conserve energy.

Fatigue represents a constant companion for many with lung disorders. When the body doesn't receive adequate oxygen, tiredness naturally follows. This exhaustion isn't the kind that improves with a good night's sleep—it's persistent and can make even thinking clearly feel difficult. People often need to prioritize their limited energy, carefully choosing which activities matter most and letting go of others.

Emotional and mental health impacts can be profound. Struggling to breathe creates understandable anxiety and fear, particularly during severe episodes. Many people experience depression as they grieve the loss of their former physical capabilities and independence. The uncertainty of living with a chronic, often progressive condition weighs heavily. Some individuals withdraw socially, avoiding activities they once enjoyed because of embarrassment about symptoms like coughing or needing supplemental oxygen, or fear of triggering breathlessness.

Work life frequently requires significant adjustments. Some people can continue working with accommodations like more flexible schedules, ability to work from home, or modifications to job duties that reduce physical demands. Others find they can no longer maintain employment, facing difficult financial and identity challenges. Even hobbies and recreational activities may need to be reconsidered, though many can be adapted rather than abandoned entirely.

Nutrition can become surprisingly complicated. Some people struggle to eat enough because shortness of breath and fatigue make mealtimes exhausting. Eating smaller, more frequent meals throughout the day and resting before meals can help. Others need to be mindful about maintaining healthy weight—both excessive weight and being underweight can worsen breathing problems. A nutritious diet with fresh fruits, vegetables, whole grains, and fish may help protect lung function.

Despite these challenges, many people with lung disorders find meaningful ways to adapt. Staying as physically active as possible, within safe limits determined by healthcare providers, helps maintain strength and overall wellness. Even gentle activities like walking strengthen breathing muscles and improve endurance over time. Learning and practicing breathing techniques such as pursed-lip breathing can help manage episodes of breathlessness more effectively.

Pulmonary rehabilitation programs offer structured support in managing daily life with lung disease. These supervised programs combine exercise training, education about the disease, breathing techniques, and strategies for managing symptoms. Participants often report improved quality of life, better ability to handle daily activities, and increased confidence in managing their condition.

How Families Can Support Patients Considering Clinical Trials

When standard treatments aren't providing adequate relief or when a lung disease proves difficult to manage, clinical trials may offer access to new approaches being tested by researchers. For families supporting a loved one with lung disease, understanding clinical trials and how to help can be invaluable.

Clinical trials are research studies that test whether new treatments, medications, or medical devices are safe and effective. They represent how all approved treatments first became available—through careful testing in volunteer participants. For lung diseases, trials might test new medications, different combinations of existing treatments, novel medical devices, or innovative approaches to managing symptoms.

Family members can help by first learning about clinical trials alongside their loved one. Many reputable websites maintain databases of current trials recruiting participants for various lung conditions. Understanding what participation involves—including potential benefits and risks, time commitments, and any travel requirements—helps everyone make informed decisions together.

One practical way families can assist is by helping organize medical information. Clinical trials have specific eligibility criteria, and having complete medical records, lists of current medications, and documentation of previous treatments readily available streamlines the screening process. Family members can help track down these documents and create organized files.

Transportation and appointment management represent another area where support proves invaluable. Clinical trials typically require more frequent visits than standard care, particularly in early phases. Offering to drive to appointments, help keep track of the schedule, or accompany the patient to study visits provides both practical assistance and emotional support.

Families should also encourage open discussions with the healthcare team. Bringing questions about trial participation to doctor's appointments, asking for explanations of anything unclear, and expressing any concerns helps ensure the patient has the information needed to make the best decision. Healthcare providers can often provide referrals to appropriate trials or connect patients with research coordinators who specialize in explaining study details.

It's important for families to remember that participating in a clinical trial is always completely voluntary. Patients can withdraw at any time, for any reason, without any negative impact on their standard medical care. The decision should never feel pressured, and both patient and family should feel comfortable with the choice, whatever it may be.

Finally, families can help by recognizing and supporting the patient's role as an active participant in their own care. People with lung disease are not passive recipients of treatment—they are partners with their medical team, making important decisions about their health. Respecting this autonomy while offering support creates the best environment for facing the challenges of chronic lung disease together.

Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Bronchodilators (including Albuterol, Levalbuterol, Salbutamol, Terbutaline, Salmeterol, Formoterol, Indacaterol, Tiotropium, Glycopyronium, Aclidinium) – These medications relax the muscles in airways to make breathing easier, available in both short-acting forms for immediate relief and long-acting forms for ongoing symptom control.
  • Corticosteroids (including Prednisone, Methylprednisolone) – These anti-inflammatory medications help reduce harmful swelling in the lungs and airways, available as inhaled or oral forms.
  • Antibiotics – Used to treat bacterial lung infections such as pneumonia and during flare-ups of chronic conditions like bronchiectasis.
  • Theophylline and Aminophylline – Bronchodilator tablets that reduce inflammation in airways and relax airway muscles.
  • Mucolytics (including Carbocisteine and Acetylcysteine) – These medications thin mucus in the airways, making it easier to cough up.
  • Nintedanib and Pirfenidone – Antifibrotic medications specifically for treating idiopathic pulmonary fibrosis to slow disease progression.

Did you know?

  1. On a typical day, you breathe approximately 25,000 times without even thinking about it, but lung disease can make every single breath a conscious effort.
  2. Despite diagnostic test results influencing about 70% of healthcare decisions, only 3 to 5% of healthcare budgets are allocated to diagnostic services.
  3. When considered together, all types of lung disease combined rank as the third leading cause of death in the United States, affecting tens of millions of Americans.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Lung disorder

Recruiting trials first

See all 3 trials →
Quick filters

3 clinical trials in this condition

Lung disorder

Not recruiting
Registered drug
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Osimertinib
  • Sponsor:Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Lung disorder

Not recruiting
Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Baricitinib
  • Sponsor:Oslo University Hospital HF
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Bemcentinib
  • Sponsor:Oslo University Hospital HF
See all 3 trials →filters applied: condition = Lung disorder

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).